Sign in
4

Changes in Ownership

Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-062490

Director sold 4,730 shares at $24.18 ($114,371)

  • Director acquired 4,096 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Welgus Howard G. · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-15 Exercise or conversion : show line 1 in the form 10b5-1 +822 $6.52 $5,361 37,297 D
2026-09-15 Exercise or conversion : show line 2 in the form 10b5-1 +1,019 $7.51 $7,653 38,316 D
2026-09-15 Exercise or conversion : show line 3 in the form 10b5-1 +2,255 $8.63 $19,461 40,571 D
2026-09-15 Sale : show line 4 in the form 10b5-1 −4,730 $24.18 $114,371 35,841 D
Open-market sales · 4,730 sh · avg $24.18 · $114,371

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2026-09-15 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (right to buy) −822 6,574 D
2026-09-15 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (right to buy) −1,019 8,144 D
2026-09-15 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (right to buy) −2,255 18,032 D
Loading xslF345X06/wk-form4_1789675580.xml…